Coronary Artery Bypass Graft Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy
Conditions: Anticoagulation; Coronary Endarterectomy Intervention: Drug: Warfarin Sponsor: China National Center for Cardiovascular Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials
Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy
Conditions: Anticoagulation; Coronary Endarterectomy Interventions: Drug: Warfarin; Drug: DAPT; Other: CE+CABG Sponsor: China National Center for Cardiovascular Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials
Effect of Dexmedetomidine on Left Ventricular Function in Coronary Artery Bypass Graft Surgery Outcome
Condition: Effect of Drug in CABAG Patients Interventions: Drug: Dexmedetomidine; Other: normal saline Sponsor: Ain Shams University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2023 Category: Research Source Type: clinical trials
